Literature DB >> 30123962

Sporadic Creutzfeldt-Jakob disease with glial PrPRes nuclear and perinuclear immunoreactivity.

Ivan Fernández-Vega1,2, Daniela Díaz-Lucena3,4, Itxaso Azkune Calle5, Maria Geijo6, Ramon A Juste6, Franc Llorens3,4, Ikerne Vicente Etxenausia2, Jorge Santos-Juanes7, Juan Jose Zarranz Imirizaldu8, Isidro Ferrer3,4,9,10.   

Abstract

Proteinase K-resistant prion protein (PrPRes ) nuclear and perinuclear immunoreactivity in oligodendrocytes of the frontal cortex is found in one case of otherwise typical sporadic Creutzfeldt-Jakob disease (sCJD) type VV2a. The PrP nature of the inclusions is validated with several anti-PrP antibodies directed to amino acids 130-160 (12F10), 109-112 (3F4), 97-102 (8G8) and the octarepeat region (amino acids 59-89: SAF32). Cellular identification and subcellular localization were evaluated with double- and triple-labeling immunofluorescence and confocal microscopy using antibodies against PrP, glial markers, and histone H3. Based on review of the literature and our own experience, this is a very odd situation that deserves further validation in other cases.
© 2018 Japanese Society of Neuropathology.

Entities:  

Keywords:  Creutzfeldt-Jakob disease; astrocytes; oligodendrocytes; prion

Mesh:

Substances:

Year:  2018        PMID: 30123962     DOI: 10.1111/neup.12505

Source DB:  PubMed          Journal:  Neuropathology        ISSN: 0919-6544            Impact factor:   1.906


  2 in total

1.  Differential astrocyte and oligodendrocyte vulnerability in murine Creutzfeldt-Jakob disease.

Authors:  Pol Andrés-Benito; Margarita Carmona; Jean Yves Douet; Hervé Cassard; Olivier Andreoletti; Isidro Ferrer
Journal:  Prion       Date:  2021-12       Impact factor: 3.931

2.  Histotype-Dependent Oligodendroglial PrP Pathology in Sporadic CJD: A Frequent Feature of the M2C "Strain".

Authors:  Ellen Gelpi; Sigrid Klotz; Nuria Vidal-Robau; Gerda Ricken; Günther Regelsberger; Thomas Ströbel; Ognian Kalev; Marlene Leoni; Herbert Budka; Gabor G Kovacs
Journal:  Viruses       Date:  2021-09-09       Impact factor: 5.048

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.